What changed in Anteris Technologies Global Corp.'s 2025 10-K compared to 2024?

Across the narrative sections we track, Anteris Technologies Global Corp. (AVR) added 0 paragraphs, removed 0, and edited 0 between the 2024 and 2025 10-K filings. The biggest movers are .

Where does this AVR 10-K diff come from?

The source filings are Anteris Technologies Global Corp.'s official 2024 and 2025 Form 10-K annual reports from SEC EDGAR. 10q10k.net parses each filing, aligns paragraphs by section (Item 1, 1A, 1C, 2, 3, 7, 7A), and highlights every added, removed and edited sentence side-by-side.

Anteris Technologies Global Corp.AVR财报

Nasdaq · 医疗保健 · 骨科、假肢及手术器械与用品

深度分析

Anteris Technologies Global Corp is a medical technology firm specializing in innovative structural heart care solutions. It develops and commercializes bioprosthetic heart valves and transcatheter intervention products, serving healthcare providers across North America, Europe, and Asia-Pacific, with core focus on cardiac surgery and interventional cardiology segments.

What changed in Anteris Technologies Global Corp.'s 10-K — 2024 vs 2025

No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.